You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):子公司擬不超14.89億元收購天士營銷
格隆匯 06-12 20:52

格隆匯6月12日丨重藥控股(000950.SZ)公佈,公司下屬控股子公司重慶醫藥(集團)股份有限公司(“重藥股份”)擬以不高於每股9.41元,收購天津天士力醫藥營銷集團股份有限公司(“天士營銷”)不低於158,190,239股的股份。包括如下兩部分:

(1)收購天士力醫藥集團股份有限公司、天津致臻科技發展合夥企業(有限合夥)、天津晟隆科技發展合夥企業(有限合夥)、天津善祺科技發展合夥企業(有限合夥)、天津瑞展科技發展合夥企業(有限合夥)、天津瑾祥科技發展合夥企業(有限合夥)、天津瑞臻科技發展合夥企業(有限合夥)(“天士力等7位交易對方”)所持有的天士營銷158,190,239股的股份,股份價款合計不超過1,488,570,148.99元;

(2)何朋飛持有的87,400股天士營銷的股份,股份價款合計不超過822,434元,該等股份待符合轉讓條件後,由天士力醫藥集團股份有限公司(“天士力”)先行收購,重藥股份再以不高於9.41/股的價格向天士力收購,若完成以上全部股份收購,合計158,277,639股,佔天士營銷總股本的100%股份價款合計不超過約14.89億元。

此次交易完成後,天士營銷將成為上市公司合併報表範圍內的子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account